BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 385274)

  • 1. Penfluridol: a neuroleptic drug designed for long duration of action.
    Migdalof BH; Grindel JM; Heykants JJ; Janssen PA
    Drug Metab Rev; 1979; 9(2):281-99. PubMed ID: 385274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The comparative metabolism and disposition of penfluridol-3H in the rat, rabbit, dog, and man.
    Grindel JM; Migdalof BH; Cressman WA
    Drug Metab Dispos; 1979; 7(5):325-9. PubMed ID: 40775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Position of the delayed-action neuroleptic penfluridol (Longperidol/Janssen) in psychiatric therapy].
    Lange E; König L; Glitschka A; Waldmann KD; Degenhardt T; Niedermeyer K; Zielonka VS; Kühne GE; Schmidt P; Graf K
    Psychiatr Neurol Med Psychol (Leipz); 1976 Aug; 28(8):466-70. PubMed ID: 1005544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penfluridol steady-state kinetics in psychiatric patients.
    Cooper SF; Dugal R; Albert JM; Bertrand M
    Clin Pharmacol Ther; 1975 Sep; 18(3):325-9. PubMed ID: 1100301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penfluridol: a long acting oral antipsychotic drug.
    Claghorn JL; Mathew RJ; Mirabi M
    J Clin Psychiatry; 1979 Feb; 40(2):107-9. PubMed ID: 368045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Activity of a new neuroleptic, penfluridol (R-16341) in long-term treatments].
    Suárez Richards M; Mario Zelaschi N; Canero E
    Acta Psiquiatr Psicol Am Lat; 1976 Sep; 22(3):205-10. PubMed ID: 983750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loading--a beneficial therapeutic effect using an oral long-acting drug, Penfluridol (SEMAP). A pilot study.
    Munitz H; Shalev A
    Isr J Psychiatry Relat Sci; 1986; 23(3):215-20. PubMed ID: 3570715
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical evaluation of penfluridol--a neuroleptic with prolonged action (oral administration) in the treatment of schizophrenic psychoses].
    Majczak A; Wielosz M; Grzywa A; Kornacki L; Nagay J; Jasińska M
    Psychiatr Pol; 1978; 12(5-6):555-62. PubMed ID: 724849
    [No Abstract]   [Full Text] [Related]  

  • 9. A long term comparative trial of penfluridol and fluphenazine decanoate in schizophrenic outpatients.
    Iqbal MJ; Young MA; Charles J; Elgart B; Von Greiff H; Simpson GM
    J Clin Psychiatry; 1978 Apr; 39(4):375-9. PubMed ID: 580285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A one-year double-blind comparison of long-acting oral (penfluridol) versus long-acting injectable (fluphenazine decanoate) antipsychotic drugs in multiple-episode schizophrenics.
    Quitkin F; Rifkin A; Klein DF
    Psychopharmacol Bull; 1977 Jul; 13(3):27-9. PubMed ID: 329327
    [No Abstract]   [Full Text] [Related]  

  • 11. [Biological fate of 3H-labeled penfluridol. (3) Correlation between concentration of 3H-penfluridol in the brain and its anti-methamphetamine activity].
    Nakamura S; Ishida R; Sugihara J
    Radioisotopes; 1976 Oct; 25(10):637-40. PubMed ID: 1037406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A new long-acting psychotropic substance in oral administration: penfluridol].
    Fiume S; Ciani S
    Clin Ter; 1981 Feb; 96(3):283-301. PubMed ID: 7030582
    [No Abstract]   [Full Text] [Related]  

  • 13. Antiparkinsonian drug administration and plasma levels of penfluridol, a new long-acting neuroleptic.
    Chouinard G; Annable L; Cooper S
    Commun Psychopharmacol; 1977; 1(4):325-31. PubMed ID: 615695
    [No Abstract]   [Full Text] [Related]  

  • 14. The interaction between neuroleptic treatment and sociotherapeutic approach in chronic schizophrenics. Investigations with haloperidol, penfluridol and pimozide.
    Baro F; Dom R
    Acta Psychiatr Belg; 1976; 76(5):735-58. PubMed ID: 1030923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of penfluridol in hospitalised chronic schizophrenic.
    Vaidyalingam N
    J Postgrad Med; 1990 Apr; 36(2):100-3. PubMed ID: 2097362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of a long-acting neuroleptic: penfluridol. Clinical and psychosocial evolution at a year follow-up].
    Morales E; Levy V; Schilkrut R
    Acta Psiquiatr Psicol Am Lat; 1981 Jul; 27(3):186-93. PubMed ID: 6127879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Penfluridol. Results of a year-long clinical trial].
    Woggon B
    Int Pharmacopsychiatry; 1978; 13(1):1-15. PubMed ID: 342435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gas-liquid chromatographic determination of penfluridol in plasma. A new specific technique.
    Cooper SF; Albert JM; Dugal R
    Int Pharmacopsychiatry; 1975; 10(2):78-88. PubMed ID: 1140908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The treatment of schizophrenia with long-acting oral neuroleptics: a six-month double-blind investigation of penfluridol versus trifluoperazine.
    Abuzzahab FS
    Psychopharmacol Bull; 1977 Jul; 13(3):26-7. PubMed ID: 329326
    [No Abstract]   [Full Text] [Related]  

  • 20. Penfluridol: a long-acting oral neuroleptic. A controlled study.
    Kurland AA; Ota KY; Slotnick VB
    J Clin Pharmacol; 1975; 15(8-9):611-21. PubMed ID: 1097478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.